-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 7, Kangtai Biological issued an announcement stating that its wholly-owned subsidiary, Beijing Minhai Biological Technology Co.
, Ltd.
(hereinafter referred to as "Minhai Biological"), had recently received the "Drug Registration Certificate" issued by the State Drug Administration
.
In accordance with the "Drug Administration Law of the People's Republic of China", "The People's Republic of China Vaccine Administration Law" and related regulations, after review, the freeze-dried Haemophilus influenzae type b conjugate vaccine declared by Minhai Biotech meets the relevant requirements for drug registration, and the registration is approved and issued.
Give the drug registration certificate
The freeze-dried Haemophilus influenzae type b conjugate vaccine is suitable for children from 2 months old to 5 years old.